USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Biointerface Technologies, Inc
Address:
1202 Ann Street
Madison, WI 53713
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $149,492.00 3

Award List:

ENZYME-BASED ANTISEPTIC WOUND DRESSING

Award Year / Program / Phase:
1988 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Abstract:
Topical antibacterial agents are widely used on burn wounds in an often unsuccessful attempt to prevent/treat infection.application of these antimicrobial agents requires the removal of the synthetic dressing. this is frequently painful, necessitating narcotic analgesia or general anesthesia. there… More

ENZYME BASED ANTISEPTIC WOUND DRESSING

Award Year / Program / Phase:
1988 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Abstract:
Topical antibacterial agents are widely used on burn woulds in an often unsuccessful attempt to prevent/treat infection. applications of these antimicrobial agents requires the removal of the synthetic dressing. this is frequently painful necessitating narcotic analgesia or general anesthesia. there… More

NON-PROTEIN MR CONTRAST AGENT FOR BREAST CANCER IMAGING

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$49,492.00
Agency:
HHS
Principal Investigator:
Capelli, Christopher C , Principal Investigator
Abstract:
Breast cancer is the most common malignancy in women. for cancer diagnosis, the search for concealed metastases is the single most important factor in the treatment decision for all cancer patients. even though current methods such as nmr have improved the detection of metastasis, the majority of… More